A carregar...

Development of Novel ACK1/TNK2 Inhibitors Using a Fragment-Based Approach

The tyrosine kinase ACK1, a critical signal transducer regulating survival of hormone-refractory cancers, is an important therapeutic target, for which there are no selective inhibitors in clinical trials to date. This work reports the discovery of novel and potent inhibitors for ACK1 tyrosine kinas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Med Chem
Main Authors: Lawrence, Harshani R., Mahajan, Kiran, Luo, Yunting, Zhang, Daniel, Tindall, Nathan, Huseyin, Miles, Gevariya, Harsukh, Kazi, Sakib, Ozcan, Sevil, Mahajan, Nupam P., Lawrence, Nicholas J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4605435/
https://ncbi.nlm.nih.gov/pubmed/25699576
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm501929n
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!